about
Recent insights into the role of autophagy in the pathogenesis of rheumatoid arthritisPhosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cellsTRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritisDNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritisTelomere dysfunction, autoimmunity and aging.K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.Telomerase insufficiency in rheumatoid arthritis.Optimal window of caloric restriction onset limits its beneficial impact on T-cell senescence in primatesDeficiency of the DNA repair enzyme ATM in rheumatoid arthritis.Treating autoimmune disease by targeting CD8(+) T suppressor cellsCurrent understanding of rheumatoid arthritis therapy.Advances in the current treatment of autoimmune hepatitis.Tracking and treating activated T cells.Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.Combination therapy with TNFR-Fc and CTLA4-FasL using the recombinant adeno-associated virus potently suppresses adjuvant-induced arthritis in rats.Intra-articular nuclear factor-κB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages.Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells.Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
P2860
Q26784021-E9DC4462-5851-4816-99FD-22F9DE131AEEQ28298650-6B56423D-1443-4B99-9193-8A96F9766127Q30988219-C32D348E-E721-4D85-B048-5716B95A1B01Q34474734-63174963-BDC0-4A5D-AA94-BB473C792CB7Q35806766-2453017F-1D84-4A4F-941F-AF0C33E3526CQ36056599-C0FA9FB4-E386-4DB4-A758-72C5C81B7A92Q37132884-2702B852-0C00-4FE6-A3D9-027B9207E9F9Q37137596-DC84F3B6-D797-40E1-9B53-5C27B70BC2E0Q37273198-C9C9F513-73F9-493C-94A6-6EB4491FCEBBQ37467452-79059994-9EF4-4D37-9B25-CFBD36CC4847Q37987351-87D79198-2D4D-461D-BC32-643DB35B38E2Q38000056-8B1BB2C4-D06A-4669-982B-EFCE4D2FA9F6Q38198637-EB9E1D0E-8B98-420E-8FCC-1FE19CC346EBQ38543383-40E3FBCC-EC54-40C6-86DB-8D968F40980DQ42160516-84DBF8BF-E534-4034-B8A4-822425D4EBE5Q44441249-0085FD2B-EEA4-4E35-881E-3EA4FBC11286Q46819131-D40700DC-41AB-4B1F-9D1E-C3C1E06D7C77Q53280145-60E3B2D5-FAC9-463F-9489-6F5D693A946C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
T-cell-targeted therapies in rheumatoid arthritis.
@ast
T-cell-targeted therapies in rheumatoid arthritis.
@en
type
label
T-cell-targeted therapies in rheumatoid arthritis.
@ast
T-cell-targeted therapies in rheumatoid arthritis.
@en
prefLabel
T-cell-targeted therapies in rheumatoid arthritis.
@ast
T-cell-targeted therapies in rheumatoid arthritis.
@en
P2860
P356
P1476
T-cell-targeted therapies in rheumatoid arthritis.
@en
P2093
Cornelia M Weyand
Jörg J Goronzy
P2860
P304
P356
10.1038/NCPRHEUM0142
P577
2006-04-01T00:00:00Z